Martina Urbanek

Innsbruck, Austria

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

MicroRNA Expression Profiles in Very Preterm Infants with Patent Ductus Arteriosus: A Pilot Study.

MicroRNA Expression Profiles in Very Preterm Infants with Patent Ductus Arteriosus: A Pilot Study.

Journal: Neonatology
Published: March 28, 2025

Effects of DHEA and DHEAS in Neonatal Hypoxic-Ischemic Brain Injury.

Effects of DHEA and DHEAS in Neonatal Hypoxic-Ischemic Brain Injury.

Journal: Antioxidants (Basel, Switzerland)
Published: October 25, 2024

MicroRNA Signatures in Umbilical Cord Blood of Neonates Exposed to Maternal SARS-CoV-2 Infection during Pregnancy.

MicroRNA Signatures in Umbilical Cord Blood of Neonates Exposed to Maternal SARS-CoV-2 Infection during Pregnancy.

Journal: Neonatology
Published: October 22, 2024

Factors Influencing Breast Milk Antibody Titers during the Coronavirus Disease 2019 Pandemic: An Observational Study.

Factors Influencing Breast Milk Antibody Titers during the Coronavirus Disease 2019 Pandemic: An Observational Study.

Journal: Nutrients
Published: June 25, 2024

Breast milk anti-S1RBD immunoglobulin concentrations throughout lactation: An observational report.

Breast milk anti-S1RBD immunoglobulin concentrations throughout lactation: An observational report.

Journal: Acta paediatrica (Oslo, Norway : 1992)
Published: December 29, 2022

Investigation of secretoneurin as a potential biomarker of brain injury in very preterm infants: A pilot study.

Investigation of secretoneurin as a potential biomarker of brain injury in very preterm infants: A pilot study.

Journal: PloS one
Published: November 20, 2022

MicroRNA Expression Profiles as Diagnostic and Prognostic Biomarkers of Perinatal Asphyxia and Hypoxic-Ischaemic Encephalopathy.

MicroRNA Expression Profiles as Diagnostic and Prognostic Biomarkers of Perinatal Asphyxia and Hypoxic-Ischaemic Encephalopathy.

Journal: Neonatology
Published: August 21, 2021

The effect of levomepromazine on the healthy and injured developing mouse brain - An in vitro and in vivo study.

The effect of levomepromazine on the healthy and injured developing mouse brain - An in vitro and in vivo study.

Journal: IBRO reports
Published: July 25, 2020

Excitotoxicity Alters Endogenous Secretoneurin Plasma Levels, but Supplementation with Secretoneurin Does Not Protect Against Excitotoxic Neonatal Brain Injury.

Excitotoxicity Alters Endogenous Secretoneurin Plasma Levels, but Supplementation with Secretoneurin Does Not Protect Against Excitotoxic Neonatal Brain Injury.

Journal: Neuroscience
Published: March 23, 2019

Short-, Mid-, and Long-Term Effect of Granulocyte Colony-Stimulating Factor/Stem Cell Factor and Fms-Related Tyrosine Kinase 3 Ligand Evaluated in an In Vivo Model of Hypoxic-Hyperoxic Ischemic Neonatal Brain Injury.

Short-, Mid-, and Long-Term Effect of Granulocyte Colony-Stimulating Factor/Stem Cell Factor and Fms-Related Tyrosine Kinase 3 Ligand Evaluated in an In Vivo Model of Hypoxic-Hyperoxic Ischemic Neonatal Brain Injury.

Journal: BioMed research international
Published: November 23, 2018

Administration of secretoneurin is protective in hypoxic-ischemic neonatal brain injury predominantly in the hypoxic-only hemisphere.

Administration of secretoneurin is protective in hypoxic-ischemic neonatal brain injury predominantly in the hypoxic-only hemisphere.

Journal: Neuroscience
Published: March 19, 2017

Delayed application of the haematopoietic growth factors G-CSF/SCF and FL reduces neonatal excitotoxic brain injury.

Delayed application of the haematopoietic growth factors G-CSF/SCF and FL reduces neonatal excitotoxic brain injury.

Journal: Brain research
Published: November 09, 2015
Showing 1-12 of 17

Last Updated: 09/26/2026